This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...

In this Interview, NewsMedical speaks with Amy Landreman about NanoBRET® Technology and its role in cellular target engagement. Could you start by explaining the significance of understanding cellular ...

Human-induced pluripotent stem cells (hiPSCs) give researchers in pharmaceutical and biotechnology organizations access to human cell types that otherwise are hard to obtain or work with. However, ...

From axolotls to zebrafish, stem cells possess remarkable regenerative abilities, enabling them to restore lost limbs and repair damaged organs. These extraordinary capabilities, however, are not ...

This article explores how tissue-based companion diagnostics leveraging immunohistochemistry approaches will help to select patients for targeted cancer treatments.

ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.

The transition from preclinical development to clinical trials is a critical, yet high-risk stage in drug development, with approximately 89% of drugs failing to progress through all phases of ...

Understanding how these functions impact a given compound is essential for effective preclinical drug development. Hepatocytes comprise approximately 80 % of the liver’s volume but only represent ...

You don't want to miss this! To permanently access this eBook for free, fill out the short form below. Developing robust, reproducible antibody pair-based immunoassays is critical for guiding drug ...